RARA CRAFT DATABASE for FDA Medical Devices
510(k)K230238

FDA DEVICE FACTS

BIOEASY™ U-Catch MAX Multi-Drug Test Cup, BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx

Shenzhen Bioeasy Biotechnology Co., Ltd.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEMarch 31, 2023PRODUCT CODEDJG

Indications for use

BIOEASY™ U-Catch MAX Multi-Dr ug Test Cup tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Am phetamine, Buprenorphine, Secobarbital, Oxazepam, Cocaine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamphetamine, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline and Marijuana in human urine at the cutoff concentrations of: Cut-off level 500 ng/mL 10 ng/mL 300 ng/mL 300 ng/mL 150 ng/mL 300 ng/mL 500 ng/mL 500 ng/mL 300 ng/mL 300 ng/mL 100 ng/mL 25 ng/mL 300 ng/mL 1000 ng/mL Drug (Identifier) Amphetamine (AMP) Buprenorphine (BUP) Secobarbital (BAR) Oxazepam (BZO) Cocaine (COC) 2-ethylidene-1,5-dimethyl-3, 3-diphenylpyrrolidine (ED DP) Methamphetamine (MET) Methylenedioxymethamphetamine (MDMA) Morphine (MOP 300) Meth adone (MTD) Oxycodone (OXY) Phencyclidine (PCP) d-Propoxyphene (PPX) No rtriptyline (TCA) Marijuana (THC) 50 ng/mL BIOEASY™ U-Catch MAX Multi-Drug Test Cup offers any combinations of the above listed analytes. It is for i n vitro diagnostic use only. It is intended for OTC use. The tests may yield positive results for the prescription drugs Buprenorphine, Nortriptyline, Oxazepam, Secobarbital, d- Propoxyphene, and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminar y positive result. The tests provide only preliminary results. To obtain a confirmed analytical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method. BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx tests are competitive binding, lateral flow immunochromatographic assays for qualitative and simultaneous detection of Amphetamine, Buprenorphine, Secobarbit al, Oxazepam, Cocaine, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, Methamphetamine, Methylenedioxymethamp hetamine, Morphine, Methadone, Oxycodone, Phencyclidine, d-Propoxyphene, Nortriptyline Cannabinoids and 6-Acetylmorphine in human urine at the cutoff concentr ations of: Cut-off level 500 ng/mL 10 ng/mL 300 ng/mL 300 ng/mL 150 ng/mL 300 ng/mL 500 ng/mL 500 ng/mL 300 ng/mL 300 ng/mL 100 ng/mL 25 ng/mL 300 ng/mL 1000 ng/mL 50 ng/mL Drug (Identifier) Amphetamine (AMP) Buprenorphine (BUP) Secobarbital (BAR) Oxazepam (BZO) Cocaine (COC) 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) Methamphetamine (MET) Methylenedioxymethamphetamine (MDMA) Morphine (MOP 300) Metha done (MTD) Oxycodone (OXY) Phencyclidine (PCP) d-Propoxyphene (PPX) Nor triptyline (TCA) Cannabinoids (THC) 6-Acetylmorphine 10 ng/mL BIOEASY™ U-Catch MAX Multi-Drug Test Cup Rx offers any combinations of the above listed analytes. It is for in vitro diagnostic use only. It is intended for prescription use. The tests may yield positive results for the prescription drugs Buprenorphine, Nortriptyline, Oxazepam, Secobarbital, d- Propoxyphene, and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly in evaluating a preliminar y positive result. The tests provide only prelimin ary results. To obtain a confirmed analy tical result, a more specific alternate chemical method must be used. GC/MS or LC/MS is the recommended confirmatory method.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 19, 2026